Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells

Audrey Wetzel, Francis Bonnefoy, Cécile Chagué, Mathieu Vetter, Mélanie Couturier, Blandine Baffert, Olivier Adotévi, Philippe Saas, Sylvain Perruche

Open source

DOI: 10.3389/fimmu.2021.812171
Published: 2022-01-18
Container: Frontiers in Immunology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2021.812171,
  title = {Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells},
  author = {Audrey Wetzel and Francis Bonnefoy and Cécile Chagué and Mathieu Vetter and Mélanie Couturier and Blandine Baffert and Olivier Adotévi and Philippe Saas and Sylvain Perruche},
  year = {2022},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2021.812171},
  url = {https://doi.org/10.3389/fimmu.2021.812171}
}

RIS

TY  - JOUR
TI  - Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells
AU  - Audrey Wetzel
AU  - Francis Bonnefoy
AU  - Cécile Chagué
AU  - Mathieu Vetter
AU  - Mélanie Couturier
AU  - Blandine Baffert
AU  - Olivier Adotévi
AU  - Philippe Saas
AU  - Sylvain Perruche
PY  - 2022
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2021.812171
UR  - https://doi.org/10.3389/fimmu.2021.812171
ER  -

APA

Wetzel, A., Bonnefoy, F., Chagué, C., Vetter, M., Couturier, M., Baffert, B., Adotévi, O., Saas, P., & Perruche, S. (2022). Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2021.812171

Source records

crossref · retrieved 2026-09-25T14:19:37.725Z